SYDNEY, Feb 4 (Bernama-GLOBE NEWSWIRE) — George Clinical announces that the organization has been accredited by the Australian Office of the Gene Technology Regulator (OGTR) which allows it to be a licence holder for studies involving the use of genetically modified organisms (GMOs).
The addition of this capability means that George Clinical can now, under the Gene Technology Act 2000 and Gene Technology Regulations 2001, undertake DIR (dealings involving intentional release) and DNIR (dealings not involving intentional release) licensing and execute studies inclusive of the required writing of DIR and DNIR applications as well as IBC (Institutional Biosafety Committee) review. Being OGTR accredited enables George Clinical to hold a license in the name of a sponsoring company.
- Croatia To Provide One-Million-Euro Humanitarian Aid To Gaza: Minister
- Security Council Extends Mandate Of UN Force In Lebanon For Final Time
- Three More Palestinian Camps In Lebanon Hand Over Weapons To Army
- U.S. Envoy Cuts Short Lebanon Border Tour Amid Protests, Backlash Over Press Remarks
- All UN Security Council Members, Except U.S., Call For Gaza Ceasefire
- Russia Says It Hit Ukrainian Military-Industrial Enterprises, Airbases
- Israeli Strikes Hit Southern Damascus Countryside
- Malaysia, Brunei To Boost Economic Ties, Infrastructure Integration
- UN Urges Cessation Of Hostilities To Halt Famine Expansion In Gaza
- Türkiye Delivers Components Of Domestic Steel Dome Air Defence System